Patrick O'Donnell Joins Medical Capital Advisors

WALTHAM, Mass., April 28 /PRNewswire/ -- With over 16 years of medical device commercialization and strategic marketing experience, Patrick O'Donnell joins Waltham, MA-based medical technology investment firm Medical Capital Advisors as President and CEO of Curative Biosciences, Inc. and Mobius Medical Holding & Distribution Company, LLC. In this role, Mr. O'Donnell will oversee the early stage funding and strategic development of these organizations as well as oversee the development of their respective technology platforms and implementation of commercial activities.

Prior to joining the Medical Capital Development team, Mr. O'Donnell led the global marketing organization for biomaterial medical device start-up company Confluent Surgical, Inc. While at Confluent Surgical, Mr. O'Donnell was responsible for the global launch of the organization's flagship hydrogel technology, DuraSeal(TM), into the neurosurgical market through an independent sales network. Mr. O'Donnell was also responsible for building the technology's value in spine, thoracic, and vascular markets. In 2007, Mr. O'Donnell played a participatory role in the $245 million acquisition and subsequent integration of Confluent Surgical by Tyco Healthcare, now Covidien.

Prior to Confluent Surgical, Mr. O'Donnell spent 13 years in the spine, orthobiologics, and orthopaedics industry at Johnson & Johnson's DePuy Spine primarily in sales, sales management and marketing capacities.

Mr. O'Donnell received his B.A. degree from the University of Wisconsin- Madison and his addition to the multidisciplinary team further strengthens Medical Capital Advisors position as a leader in the medical technology industry.

About Medical Capital Group

Medical Capital Group is a healthcare merchant banking firm providing strategic and investment banking services and financing to leading medical technology and healthcare companies. Through deep domain expertise and a multi-disciplinary team approach, MedCap delivers a paramount level of market insight and client service to firms who wish to access capital through merger, acquisition, private equity/venture capital financing, or strategic partnerships. For more information on Curative Biosciences or Mobius Medical Holding & Distribution Company, please visit or call (781) 839-7364.

SOURCE Medical Capital Group

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.